Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

Efficacy and safety of topical and systemic medications: a systematic literature review informing the EULAR recommendations for the management of Sjögren's syndrome.

Brito-Zerón P, Retamozo S, Kostov B, Baldini C, Bootsma H, De Vita S, Dörner T, Gottenberg JE, Kruize AA, Mandl T, Ng WF, Seror R, Tzioufas AG, Vitali C, Bowman S, Mariette X, Ramos-Casals M.

RMD Open. 2019 Oct 28;5(2):e001064. doi: 10.1136/rmdopen-2019-001064. eCollection 2019. Review.

2.

Increased risk of multiple myeloma in primary Sjögren's syndrome is limited to individuals with Ro/SSA and La/SSB autoantibodies.

Mofors J, Björk A, Smedby KE, Kvarnström M, Forsblad-d'Elia H, Magnusson-Bucher S, Eriksson P, Mandl T, Baecklund E, Nordmark G, Wahren-Herlenius M.

Ann Rheum Dis. 2019 Nov 6. pii: annrheumdis-2019-216287. doi: 10.1136/annrheumdis-2019-216287. [Epub ahead of print] No abstract available.

PMID:
31694814
3.

EULAR recommendations for the management of Sjögren's syndrome with topical and systemic therapies.

Ramos-Casals M, Brito-Zerón P, Bombardieri S, Bootsma H, De Vita S, Dörner T, Fisher BA, Gottenberg JE, Hernandez-Molina G, Kocher A, Kostov B, Kruize AA, Mandl T, Ng WF, Retamozo S, Seror R, Shoenfeld Y, Sisó-Almirall A, Tzioufas AG, Vitali C, Bowman S, Mariette X; EULAR-Sjögren Syndrome Task Force Group.

Ann Rheum Dis. 2019 Oct 31. pii: annrheumdis-2019-216114. doi: 10.1136/annrheumdis-2019-216114. [Epub ahead of print]

PMID:
31672775
4.

Associations of cigarette smoking with disease phenotype and type I interferon expression in primary Sjögren's syndrome.

Olsson P, Bodewes ILA, Nilsson AM, Turesson C, Jacobsson LTH, Theander E, Versnel MA, Mandl T.

Rheumatol Int. 2019 Sep;39(9):1575-1584. doi: 10.1007/s00296-019-04335-3. Epub 2019 May 28.

PMID:
31139950
5.

Concomitant Ro/SSA and La/SSB antibodies are biomarkers for the risk of venous thromboembolism and cerebral infarction in primary Sjögren's syndrome.

Mofors J, Holmqvist M, Westermark L, Björk A, Kvarnström M, Forsblad-d'Elia H, Magnusson Bucher S, Eriksson P, Theander E, Mandl T, Wahren-Herlenius M, Nordmark G.

J Intern Med. 2019 Oct;286(4):458-468. doi: 10.1111/joim.12941. Epub 2019 Jun 17.

6.

Infections increase the risk of developing Sjögren's syndrome.

Mofors J, Arkema EV, Björk A, Westermark L, Kvarnström M, Forsblad-d'Elia H, Magnusson Bucher S, Eriksson P, Mandl T, Nordmark G, Wahren-Herlenius M.

J Intern Med. 2019 Jun;285(6):670-680. doi: 10.1111/joim.12888. Epub 2019 Apr 17.

PMID:
30892751
7.

Antibody response to 13-valent pneumococcal conjugate vaccine is not impaired in patients with rheumatoid arthritis or primary Sjögren's syndrome without disease modifying treatment.

Nived P, Saxne T, Geborek P, Mandl T, Skattum L, Kapetanovic MC.

BMC Rheumatol. 2018 Apr 5;2:12. doi: 10.1186/s41927-018-0019-6. eCollection 2018.

8.

Increased B-cell activating factor, interleukin-6, and interleukin-8 in induced sputum from primary Sjögren's syndrome patients.

Nilsson AM, Tufvesson E, Hesselstrand R, Olsson P, Wollmer P, Mandl T.

Scand J Rheumatol. 2019 Mar;48(2):149-156. doi: 10.1080/03009742.2018.1473488. Epub 2018 Sep 30.

PMID:
30270699
9.

How immunological profile drives clinical phenotype of primary Sjögren's syndrome at diagnosis: analysis of 10,500 patients (Sjögren Big Data Project).

Brito-Zerón P, Acar-Denizli N, Ng WF, Zeher M, Rasmussen A, Mandl T, Seror R, Li X, Baldini C, Gottenberg JE, Danda D, Quartuccio L, Priori R, Hernandez-Molina G, Armagan B, Kruize AA, Kwok SK, Kvarnström M, Praprotnik S, Sène D, Bartoloni E, Solans R, Rischmueller M, Suzuki Y, Isenberg DA, Valim V, Wiland P, Nordmark G, Fraile G, Bootsma H, Nakamura T, Giacomelli R, Devauchelle-Pensec V, Knopf A, Bombardieri M, Trevisani VF, Hammenfors D, Pasoto SG, Retamozo S, Gheita TA, Atzeni F, Morel J, Vollenveider C, Horvath IF, Sivils KL, Olsson P, De Vita S, Sánchez-Guerrero J, Kilic L, Wahren-Herlenius M, Mariette X, Ramos-Casals M; Sjögren Big Data Consortium.

Clin Exp Rheumatol. 2018 May-Jun;36 Suppl 112(3):102-112. Epub 2018 Aug 14.

10.

Autoantibodies to Cytosolic 5'-Nucleotidase 1A in Primary Sjögren's Syndrome and Systemic Lupus Erythematosus.

Rietveld A, van den Hoogen LL, Bizzaro N, Blokland SLM, Dähnrich C, Gottenberg JE, Houen G, Johannsen N, Mandl T, Meyer A, Nielsen CT, Olsson P, van Roon J, Schlumberger W, van Engelen BGM, Saris CGJ, Pruijn GJM.

Front Immunol. 2018 Jun 5;9:1200. doi: 10.3389/fimmu.2018.01200. eCollection 2018.

11.

Smoking, disease characteristics and serum cytokine levels in patients with primary Sjögren's syndrome.

Olsson P, Skogstrand K, Nilsson A, Turesson C, Jacobsson LTH, Theander E, Houen G, Mandl T.

Rheumatol Int. 2018 Aug;38(8):1503-1510. doi: 10.1007/s00296-018-4063-8. Epub 2018 May 30.

12.

Epidemiology of hypocomplementaemic urticarial vasculitis (anti-C1q vasculitis).

Sjöwall C, Mandl T, Skattum L, Olsson M, Mohammad AJ.

Rheumatology (Oxford). 2018 Aug 1;57(8):1400-1407. doi: 10.1093/rheumatology/key110.

PMID:
29718374
13.

Severe intestinal dysbiosis is prevalent in primary Sjögren's syndrome and is associated with systemic disease activity.

Mandl T, Marsal J, Olsson P, Ohlsson B, Andréasson K.

Arthritis Res Ther. 2017 Oct 24;19(1):237. doi: 10.1186/s13075-017-1446-2.

14.

Long-term follow-up in primary Sjögren's syndrome reveals differences in clinical presentation between female and male patients.

Ramírez Sepúlveda JI, Kvarnström M, Eriksson P, Mandl T, Norheim KB, Johnsen SJ, Hammenfors D, Jonsson MV, Skarstein K, Brun JG; DISSECT consortium, Rönnblom L, Forsblad-d'Elia H, Magnusson Bucher S, Baecklund E, Theander E, Omdal R, Jonsson R, Nordmark G, Wahren-Herlenius M.

Biol Sex Differ. 2017 Aug 8;8(1):25. doi: 10.1186/s13293-017-0146-6.

15.

Cigarette smoking and the risk of primary Sjögren's syndrome: a nested case control study.

Olsson P, Turesson C, Mandl T, Jacobsson L, Theander E.

Arthritis Res Ther. 2017 Mar 7;19(1):50. doi: 10.1186/s13075-017-1255-7.

16.

Respiratory symptoms are poor predictors of concomitant chronic obstructive pulmonary disease in patients with primary Sjögren's syndrome.

Strevens Bolmgren V, Olsson P, Wollmer P, Hesselstrand R, Mandl T.

Rheumatol Int. 2017 May;37(5):813-818. doi: 10.1007/s00296-017-3678-5. Epub 2017 Feb 27.

17.

Work Disability in Newly Diagnosed Patients with Primary Sjögren Syndrome.

Mandl T, Jørgensen TS, Skougaard M, Olsson P, Kristensen LE.

J Rheumatol. 2017 Feb;44(2):209-215. doi: 10.3899/jrheum.160932. Epub 2016 Nov 15.

PMID:
28148755
18.

Influence of geolocation and ethnicity on the phenotypic expression of primary Sjögren's syndrome at diagnosis in 8310 patients: a cross-sectional study from the Big Data Sjögren Project Consortium.

Brito-Zerón P, Acar-Denizli N, Zeher M, Rasmussen A, Seror R, Theander E, Li X, Baldini C, Gottenberg JE, Danda D, Quartuccio L, Priori R, Hernandez-Molina G, Kruize AA, Valim V, Kvarnstrom M, Sene D, Gerli R, Praprotnik S, Isenberg D, Solans R, Rischmueller M, Kwok SK, Nordmark G, Suzuki Y, Giacomelli R, Devauchelle-Pensec V, Bombardieri M, Hofauer B, Bootsma H, Brun JG, Fraile G, Carsons SE, Gheita TA, Morel J, Vollenveider C, Atzeni F, Retamozo S, Horvath IF, Sivils K, Mandl T, Sandhya P, De Vita S, Sanchez-Guerrero J, van der Heijden E, Trevisani VFM, Wahren-Herlenius M, Mariette X, Ramos-Casals M; EULAR-SS Task Force Big Data Consortium.

Ann Rheum Dis. 2017 Jun;76(6):1042-1050. doi: 10.1136/annrheumdis-2016-209952. Epub 2016 Nov 29.

PMID:
27899373
19.

Elevated levels of faecal calprotectin in primary Sjögren's syndrome is common and associated with concomitant organic gastrointestinal disease.

Andréasson K, Ohlsson B, Mandl T.

Arthritis Res Ther. 2016 Jan 12;18:9. doi: 10.1186/s13075-015-0907-8.

20.

Early diagnosis of primary Sjögren's syndrome: EULAR-SS task force clinical recommendations.

Brito-Zerón P, Theander E, Baldini C, Seror R, Retamozo S, Quartuccio L, Bootsma H, Bowman SJ, Dörner T, Gottenberg JE, Mariette X, Bombardieri S, de Vita S, Mandl T, Ng WF, Kruize AA, Tzioufas A, Vitali C, Buyon J, Izmirly P, Fox R, Ramos-Casals M; Eular Sjögren Syndrome Task Force.

Expert Rev Clin Immunol. 2016;12(2):137-56. doi: 10.1586/1744666X.2016.1109449. Epub 2015 Dec 22. Review. Erratum in: Expert Rev Clin Immunol. 2017 May;13(5):507.

PMID:
26691952
21.

EULAR Sjögren's syndrome disease activity index (ESSDAI): a user guide.

Seror R, Bowman SJ, Brito-Zeron P, Theander E, Bootsma H, Tzioufas A, Gottenberg JE, Ramos-Casals M, Dörner T, Ravaud P, Vitali C, Mariette X, Asmussen K, Jacobsen S, Bartoloni E, Gerli R, Bijlsma JW, Kruize AA, Bombardieri S, Bookman A, Kallenberg C, Meiners P, Brun JG, Jonsson R, Caporali R, Carsons S, De Vita S, Del Papa N, Devauchelle V, Saraux A, Fauchais AL, Sibilia J, Hachulla E, Illei G, Isenberg D, Jones A, Manoussakis M, Mandl T, Jacobsson L, Demoulins F, Montecucco C, Ng WF, Nishiyama S, Omdal R, Parke A, Praprotnik S, Tomsic M, Price E, Scofield H, L Sivils K, Smolen J, Laqué RS, Steinfeld S, Sutcliffe N, Sumida T, Valesini G, Valim V, Vivino FB, Vollenweider C.

RMD Open. 2015 Feb 20;1(1):e000022. doi: 10.1136/rmdopen-2014-000022. eCollection 2015. Review.

22.

Characterization of systemic disease in primary Sjögren's syndrome: EULAR-SS Task Force recommendations for articular, cutaneous, pulmonary and renal involvements.

Ramos-Casals M, Brito-Zerón P, Seror R, Bootsma H, Bowman SJ, Dörner T, Gottenberg JE, Mariette X, Theander E, Bombardieri S, De Vita S, Mandl T, Ng WF, Kruize A, Tzioufas A, Vitali C; EULAR Sjögren Syndrome Task Force.

Rheumatology (Oxford). 2015 Dec;54(12):2230-8. doi: 10.1093/rheumatology/kev200. Epub 2015 Jul 31. Erratum in: Rheumatology (Oxford). 2017 Jul 1;56(7):1245.

23.

Takayasu arteritis in southern Sweden.

Mohammad AJ, Mandl T.

J Rheumatol. 2015 May;42(5):853-8. doi: 10.3899/jrheum.140843. Epub 2015 Mar 15.

PMID:
25774057
24.

Chronic obstructive pulmonary disease is common in never-smoking patients with primary Sjögren syndrome.

Nilsson AM, Diaz S, Theander E, Hesselstrand R, Piitulainen E, Ekberg O, Wollmer P, Mandl T.

J Rheumatol. 2015 Mar;42(3):464-71. doi: 10.3899/jrheum.140370. Epub 2015 Jan 15.

PMID:
25593235
25.

Defining disease activity states and clinically meaningful improvement in primary Sjögren's syndrome with EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI).

Seror R, Bootsma H, Saraux A, Bowman SJ, Theander E, Brun JG, Baron G, Le Guern V, Devauchelle-Pensec V, Ramos-Casals M, Valim V, Dörner T, Tzioufas A, Gottenberg JE, Solans Laqué R, Mandl T, Hachulla E, Sivils KL, Ng WF, Fauchais AL, Bombardieri S, Priori R, Bartoloni E, Goeb V, Praprotnik S, Sumida T, Nishiyama S, Caporali R, Kruize AA, Vollenweider C, Ravaud P, Meiners P, Brito-Zerón P, Vitali C, Mariette X; EULAR Sjögren's Task Force.

Ann Rheum Dis. 2016 Feb;75(2):382-9. doi: 10.1136/annrheumdis-2014-206008. Epub 2014 Dec 5.

PMID:
25480887
26.

Antibodies against GnRH and its receptor in patients with primary Sjögren's syndrome.

Mandl T, Roth B, Ohlsson B.

Scand J Rheumatol. 2014;43(4):338-48. doi: 10.3109/03009742.2013.878388. Epub 2014 Apr 2. No abstract available.

PMID:
24689972
27.

Faecal levels of calprotectin in systemic sclerosis are stable over time and are higher compared to primary Sjögren's syndrome and rheumatoid arthritis.

Andréasson K, Saxne T, Scheja A, Bartosik I, Mandl T, Hesselstrand R.

Arthritis Res Ther. 2014 Feb 6;16(1):R46. doi: 10.1186/ar4475.

28.

Validation of EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient indexes (ESSPRI).

Seror R, Theander E, Brun JG, Ramos-Casals M, Valim V, Dörner T, Bootsma H, Tzioufas A, Solans-Laqué R, Mandl T, Gottenberg JE, Hachulla E, Sivils KL, Ng WF, Fauchais AL, Bombardieri S, Valesini G, Bartoloni E, Saraux A, Tomsic M, Sumida T, Nishiyama S, Caporali R, Kruize AA, Vollenweider C, Ravaud P, Vitali C, Mariette X, Bowman SJ; EULAR Sjögren's Task Force.

Ann Rheum Dis. 2015 May;74(5):859-66. doi: 10.1136/annrheumdis-2013-204615. Epub 2014 Jan 17.

PMID:
24442883
29.

The forced oscillation technique is a sensitive method for detecting obstructive airway disease in patients with primary Sjögren's syndrome.

Nilsson AM, Theander E, Hesselstrand R, Piitulainen E, Wollmer P, Mandl T.

Scand J Rheumatol. 2014;43(4):324-8. doi: 10.3109/03009742.2013.856466. Epub 2014 Jan 7.

PMID:
24392743
30.

Primary Sjögren's syndrome: diagnostic and prognostic value of salivary gland ultrasonography using a simplified scoring system.

Theander E, Mandl T.

Arthritis Care Res (Hoboken). 2014 Jul;66(7):1102-7. doi: 10.1002/acr.22264.

31.

Autoantibodies and gastrointestinal symptoms in infertile women in relation to in vitro fertilization.

Hammar O, Roth B, Bengtsson M, Mandl T, Ohlsson B.

BMC Pregnancy Childbirth. 2013 Nov 5;13:201. doi: 10.1186/1471-2393-13-201.

32.

A Quasi-Stationary Approach to the Approximate Solution of an FEA 3D Subject-Specific EMG Model.

Honeder JL, Goebel PM, Mandl T, Schachinger M.

Biomed Tech (Berl). 2013 Aug;58 Suppl 1. pii: /j/bmte.2013.58.issue-s1-N/bmt-2013-4347/bmt-2013-4347.xml. doi: 10.1515/bmt-2013-4347. Epub 2013 Sep 7. No abstract available.

PMID:
24043055
33.

Incidence, prevalence and clinical characteristics of Behcet's disease in southern Sweden.

Mohammad A, Mandl T, Sturfelt G, Segelmark M.

Rheumatology (Oxford). 2013 Feb;52(2):304-10. doi: 10.1093/rheumatology/kes249. Epub 2012 Sep 25.

PMID:
23012468
34.

Frequent development of chronic obstructive pulmonary disease in primary SS--results of a longitudinal follow-up.

Mandl T, Diaz S, Ekberg O, Hesselstrand R, Piitulainen E, Wollmer P, Theander E.

Rheumatology (Oxford). 2012 May;51(5):941-6. doi: 10.1093/rheumatology/ker409. Epub 2012 Jan 17.

PMID:
22258389
35.

Evaluation of gastrointestinal symptoms in different patient groups using the visual analogue scale for irritable bowel syndrome (VAS-IBS).

Bengtsson M, Hammar O, Mandl T, Ohlsson B.

BMC Gastroenterol. 2011 Nov 10;11:122. doi: 10.1186/1471-230X-11-122.

36.

Semi-LASER localized dynamic 31P magnetic resonance spectroscopy in exercising muscle at ultra-high magnetic field.

Meyerspeer M, Scheenen T, Schmid AI, Mandl T, Unger E, Moser E.

Magn Reson Med. 2011 May;65(5):1207-15. doi: 10.1002/mrm.22730. Epub 2011 Mar 7.

37.

EULAR Sjogren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjogren's syndrome.

Seror R, Ravaud P, Mariette X, Bootsma H, Theander E, Hansen A, Ramos-Casals M, Dörner T, Bombardieri S, Hachulla E, Brun JG, Kruize AA, Praprotnik S, Tomsic M, Gottenberg JE, Devauchelle V, Devita S, Vollenweider C, Mandl T, Tzioufas A, Carsons S, Saraux A, Sutcliffe N, Vitali C, Bowman SJ; EULAR Sjögren's Task Force.

Ann Rheum Dis. 2011 Jun;70(6):968-72. doi: 10.1136/ard.2010.143743. Epub 2011 Feb 22.

PMID:
21345815
38.

Impaired gastric emptying in primary Sjogren's syndrome.

Hammar O, Ohlsson B, Wollmer P, Mandl T.

J Rheumatol. 2010 Nov;37(11):2313-8. doi: 10.3899/jrheum.100280. Epub 2010 Sep 1.

PMID:
20810502
39.

Sleepiness or fatigue? Can we detect treatable causes of tiredness in primary Sjögren's syndrome?

Theander L, Strömbeck B, Mandl T, Theander E.

Rheumatology (Oxford). 2010 Jun;49(6):1177-83. doi: 10.1093/rheumatology/keq023. Epub 2010 Mar 22.

PMID:
20308122
40.

Autonomic nervous dysfunction development in patients with primary Sjogren's syndrome: a follow-up study.

Mandl T, Hammar O, Theander E, Wollmer P, Ohlsson B.

Rheumatology (Oxford). 2010 Jun;49(6):1101-6. doi: 10.1093/rheumatology/keq042. Epub 2010 Mar 10.

PMID:
20219783
41.

Functional bowel symptoms and GnRH antibodies: common findings in patients with primary Sjögren's syndrome but not in systemic sclerosis.

Ohlsson B, Scheja A, Janciauskiene S, Mandl T.

Scand J Rheumatol. 2009;38(5):391-3. doi: 10.1080/03009740802709069. No abstract available.

PMID:
19308876
42.

Functional electrical stimulation of long-term denervated, degenerated human skeletal muscle: estimating activation using T2-parameter magnetic resonance imaging methods.

Mandl T, Meyerspeer M, Reichel M, Kern H, Hofer C, Mayr W, Moser E.

Artif Organs. 2008 Aug;32(8):604-8. doi: 10.1111/j.1525-1594.2008.00609.x.

PMID:
18782129
43.

Assessment of autonomic symptoms in diabetics: the Swedish version of the Autonomic Symptom Profile.

Mandl T, Granberg V, Apelqvist J, Wollmer P, Manthorpe R, Jacobsson LT.

Clin Physiol Funct Imaging. 2008 Sep;28(5):312-7. doi: 10.1111/j.1475-097X.2008.00810.x. Epub 2008 May 7.

PMID:
18462437
44.

Effects of functional electrical stimulation in denervated thigh muscles of paraplegic patients mapped with T2 imaging.

Meyerspeer M, Mandl T, Reichel M, Mayr W, Hofer C, Kern H, Moser E.

MAGMA. 2008 May;21(3):219-26. doi: 10.1007/s10334-008-0113-7. Epub 2008 Apr 19.

45.

Autonomic nervous symptoms in primary Sjogren's syndrome.

Mandl T, Granberg V, Apelqvist J, Wollmer P, Manthorpe R, Jacobsson LT.

Rheumatology (Oxford). 2008 Jun;47(6):914-9. doi: 10.1093/rheumatology/ken107. Epub 2008 Apr 14.

PMID:
18411214
46.

Dysphagia and dysmotility of the pharynx and oesophagus in patients with primary Sjögren's syndrome.

Mandl T, Ekberg O, Wollmer P, Manthorpe R, Jacobsson LT.

Scand J Rheumatol. 2007 Sep-Oct;36(5):394-401.

PMID:
17963171
47.

Autonomic and orthostatic dysfunction in primary Sjögren's syndrome.

Mandl T, Wollmer P, Manthorpe R, Jacobsson LT.

J Rheumatol. 2007 Sep;34(9):1869-74. Epub 2007 Jul 15.

PMID:
17659755
48.

Lymphoma and other malignancies in primary Sjögren's syndrome: a cohort study on cancer incidence and lymphoma predictors.

Theander E, Henriksson G, Ljungberg O, Mandl T, Manthorpe R, Jacobsson LT.

Ann Rheum Dis. 2006 Jun;65(6):796-803. Epub 2005 Nov 10.

49.

CD4+ T-lymphocytopenia--a frequent finding in anti-SSA antibody seropositive patients with primary Sjögren's syndrome.

Mandl T, Bredberg A, Jacobsson LT, Manthorpe R, Henriksson G.

J Rheumatol. 2004 Apr;31(4):726-8.

PMID:
15088298
50.

Supplemental Content

Support Center